DOB-FLY

DOB-FLY, also known as 3C-B-FLY, is a psychedelic drug and designer drug of the phenethylamine, DOx, and FLY families that was developed by David E. Nichols and colleagues at Purdue University. It can be regarded as the α-methyl derivative of 2C-B-FLY or the partially saturated counterpart of Bromo-DragonFLY. Unlike Bromo-DragonFLY, DOB-FLY is only slightly more potent than DOB itself, with an active dose in humans of around 1 mg. It is a controlled substance in Canada under phenethylamine blanket-ban language, but is not explicitly controlled in the United States.